Jacobs Levy Equity Management
MDGL icon

Jacobs Levy Equity Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jacobs Levy Equity Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,348
Closed -$85K – 1086
2016
Q2 		$85K Sell
9,348
-30,604
-77% -$367K ﹤0.01% 1104
2016
Q1 		$336K Buy
39,952
+39,526
+9,278% +$330K 0.01% 835
2015
Q4 		$5K Sell
426
-12,156
-97% -$334K ﹤0.01% 788
2015
Q3 		$766K Buy
12,582
+6,197
+97% +$447K 0.02% 522
2015
Q2 		$498K Buy
6,385
+3,914
+158% +$328K 0.01% 570
2015
Q1 		$168K Sell
2,471
-12,417
-83% -$1.06M ﹤0.01% 720
2014
Q4 		$1.38M Buy
14,888
+11,825
+386% +$1.22M 0.02% 444
2014
Q3 		$323K Buy
3,063
+26
+0.9% +$3.62K 0.01% 666
2014
Q2 		$435K Buy
+3,037
New +$444K 0.01% 662

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return